TGF-β1 latency associated peptide promotes remodeling of healing cutaneous wounds in the rat

Keyphrases

• Healing 100%
• Transforming Growth Factor-β 100%
• Cutaneous Wound 100%
• Latency-associated Peptide 100%
• Fibrosis 25%
• α-smooth muscle Actin (α-SMA) 25%
• Type I Collagen 25%
• Wound Healing 12%
• Histology 12%
• Specific Antibodies 12%
• Inflammation 12%
• Growth Factors 12%
• Tissue Repair 12%
• Extracellular Matrix Protein 1 (ECM1) 12%
• Western Blotting 12%
• Proliferating Cell nuclear Antigen 12%
• Local Administration 12%
• Inflammatory Phase 12%
• Hypertrophic Scarring 12%
• Immunohistochemical Method 12%
• Epidermis 12%
• Matrix Deposition 12%
• Granuloma Formation 12%
• Overactivity 12%
• Tissue Remodeling 12%
• Post-inflammatory 12%
• Male Adult Rats 12%
• Formation Matrix 12%
• Healing Wounds 12%
• Matrix Remodeling 12%
• Excision Wound 12%
• Remodeling Phase 12%
• Cutaneous Healing 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Wound 100%
• Fibrinogen 100%
• Skin Injury 100%
• Latency Associated Peptide 100%
• Cancer Growth Factor 100%
• Wound Healing 20%
• Fibrosis 20%
• Collagen Type 1 20%
• Smooth Muscle Actin 20%
• Antibodies 10%
• Growth Factor 10%
• Inflammation 10%
• Western Blot 10%
• Cycline 10%
• Tissue Repair 10%
• Granulation Tissue 10%
• Scar Formation 10%
• Scleroprotein 10%

Nursing and Health Professions

• Wound 100%
• Skin Injury 100%
• Fibrinogen 100%
• Latency Associated Peptide 100%
• Cancer Growth Factor 100%
• Wound Healing 20%
• Fibrosis 20%
• Collagen Type 1 20%
• Smooth Muscle Actin 20%
• Tissue Repair 10%
• Growth Factor 10%
• Inflammation 10%
• Scar Formation 10%
• Antibodies 10%
• Western Blotting 10%
• Cycline 10%
• Granulation Tissue 10%
• Scleroprotein 10%